login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Constellation Pharmaceuticals Inc (CNST) Stock News
NASDAQ:CNST - Nasdaq -
33.99
+0.02 (+0.06%)
After market: 33.99
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CNST Latest News, Press Relases and Analysis
All
Press Releases
4 years ago - By: Benzinga
- Mentions:
NERV
UPC
MOR
SYRS
...
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
4 years ago - By: MorphoSys AG
- Mentions:
MOR
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
4 years ago - By: Capital Market Laboratories
A Buy the Dip Stock Trigger in Constellation Pharmaceuticals Inc
4 years ago - By: MorphoSys AG
- Mentions:
MOR
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals
4 years ago - By: Halper Sadeh LLP
- Mentions:
CORE
MMAC
SLCT
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Halper Sadeh LLP
- Mentions:
EBSB
FMBI
SLCT
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Analyst Ratings
- Mentions:
JPM
J.P. Morgan Downgrades Constellation Pharmaceuticals (CNST) to Hold
4 years ago - By: Halper Sadeh LLP
- Mentions:
MDP
FMBI
AVCO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Barron's
- Mentions:
BIIB
SAGE
VRTX
SPX
...
Biogen's FDA Win Marks a Mini-Rally in Biotech Stocks
4 years ago - By: Halper Sadeh LLP
- Mentions:
DSSI
FMBI
SLCT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSSI, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Benzinga
- Mentions:
CRSP
MOR
ADMP
IOVA
...
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
4 years ago - By: Monteverde & Associates PC
- Mentions:
MOR
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST
4 years ago - By: Barron's
- Mentions:
PFE
CVAC
MRNA
ZIM
...
The Top-Returning IPOs of the Pandemic
Please enable JavaScript to continue using this application.
